APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review.

Emrani, Sheina; Arain, Hirra A; DeMarshall, Cassandra; Nuriel, Tal

Emrani, Sheina; Arain, Hirra A; DeMarshall, Cassandra; Nuriel, Tal.

Afiliación

Emrani S; Department of Psychology, Rowan University, 201 Mullica Hill Road, Glassboro, NJ, 08028, USA.
Arain HA; Department of Pathology and Cell Biology, Columbia University, 630 West 168th Street, New York, NY, 10032, USA.
DeMarshall C; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, 630 West 168th Street, New York, NY, 10032, USA.
Nuriel T; Department of Geriatrics and Gerontology, Rowan University School of Osteopathic Medicine, One Medical Center Drive, Stratford, NJ, 08084, USA.

Alzheimers Res Ther ; 12(1): 141, 2020 11 04.

Article en En | MEDLINE | ID: mdl-33148345

Asunto(s)

Enfermedad de Alzheimer; Apolipoproteína E4; Enfermedad de Alzheimer/genética; Apolipoproteína E4/genética; Apolipoproteínas E; Atrofia; Cognición; Humanos

Palabras clave

AD; APOE; APOE4; Alzheimer's disease; Apolipoprotein E; Heterogeneity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Apolipoproteína E4 / Enfermedad de Alzheimer Tipo de estudio: Qualitative_research / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Alzheimers Res Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google